Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Armata Pharmaceuticals Inc

ARMP
Current price
2.36 USD -0.039 USD (-1.65%)
Last closed 2.4 USD
ISIN US04216R1023
Sector Healthcare
Industry Biotechnology
Exchange NYSE
Capitalization 85 753 944 USD
Yield for 12 month +21.05 %
1Y
3Y
5Y
10Y
15Y
ARMP
21.11.2021 - 28.11.2021

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc. Address: 5005 McConnell Avenue, Los Angeles, CA, United States, 90066

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7 USD

P/E ratio

Dividend Yield

Current Year

+4 529 000 USD

Last Year

+5 508 000 USD

Current Quarter

Last Quarter

+966 000 USD

Current Year

-29 241 000 USD

Last Year

+4 616 000 USD

Current Quarter

-315 000 USD

Last Quarter

+649 000 USD

Key Figures ARMP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -40 911 000 USD
Operating Margin TTM -1130.87 %
PE Ratio
Return On Assets TTM -25.09 %
PEG Ratio
Return On Equity TTM -3439.35 %
Wall Street Target Price 7 USD
Revenue TTM 3 719 000 USD
Book Value -1.28 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 21.4 %
Dividend Yield
Gross Profit TTM -29 509 000 USD
Earnings per share -1.86 USD
Diluted Eps TTM -1.86 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ARMP

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ARMP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:14
Payout Ratio
Last Split Date 10.05.2019
Dividend Date 10.05.2019

Stock Valuation ARMP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 148.1376
Price Sales TTM 23.0583
Enterprise Value EBITDA -3.4738
Price Book MRQ 4.0597

Financials ARMP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ARMP

For 52 weeks

1.9 USD 4.48 USD
50 Day MA 2.37 USD
Shares Short Prior Month 7 034
200 Day MA 2.97 USD
Short Ratio 0.58
Shares Short 3 372
Short Percent 0.03 %